PEY

Retail pharmacy giant Walgreens Boots Alliance Inc (NASDAQ:WBA) is bolstering its specialty pharmacy services, aiming to enhance patient outcomes and value for stakeholders. The company unveiled Walgreens Specialty Pharmacy, an encompassing initiative to cater to patients with complex, chronic conditions while fostering profitable partnerships. Read Next: Walgreens Challenges Nearly $1B Arbitration Award Over Alleged Breach of COVID-19 Test Business Contract Walgreens Specialty Pharmacy introduces a comprehensive suite of services, including gene and cell therapy solutions, marking a significant advancement in the company’s healthcare offerings. Anchored by an 18,000-square-foot

  Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter. • Trevena (NASDAQ:TRVN) is projected to report earnings for its first quarter. • Life Time Group Hldgs (NYSE:LTH) is likely to report quarterly loss at $0.41 per share on revenue of $356.56 million. • Endeavor Gr Hldgs (NYSE:EDR) is estimated to report quarterly earnings at $0.06 per share on revenue of $66.60 million. • Ondas Holdings (NASDAQ:ONDS) is expected to report quarterly loss at $0.17 per share on revenue of $910.00 thousand. • Performance Food Group (NYSE:PFGC) is projected to report quarterly earnings at $0.51 per share on revenue of $13.09 billion.

  Companies Reporting Before The Bell • REV Group (NYSE:REVG) is expected to report quarterly earnings at $0.11 per share on revenue of $529.44 million. • Express (NYSE:EXPR) is projected to report quarterly loss at $0.02 per share on revenue of $591.95 million. • Campbell Soup (NYSE:CPB) is expected to report quarterly earnings at $0.69 per share on revenue of $2.24 billion. • PureCycle Technologies (NASDAQ:PCT) is expected to report earnings for its fourth quarter. • BrainsWay (NASDAQ:BWAY) is expected to report quarterly loss at $0.07 per share on revenue of $7.98 million. • Children's Place (NASDAQ:PLCE) is expected to report quarterly earnings at $2.85 per share on revenue of $53

RBC Capital reiterated coverage of Peyto Exploration & Dev with a rating of Sector Perform and set a new price target of $13.00 from $12.00 previously

TD Securities upgraded Peyto Exploration & Dev from Hold to Buy and set a new price target of $10.00 from $6.50 previously